BioSpace News Archive

Drug Development

Exelixis, Inc. Release: Cabozantinib Demonstrates Durable Effects in Bone and Soft Tissue in Advanced Prostate Cancer

June 5, 2012
·
1 min read
Business

Pioneer of Postmortem Toxicology Joins NMS Labs

June 5, 2012
·
1 min read
XTL Biopharmaceuticals Ltd. Files Application for Listing on the NASDAQ

June 5, 2012
·
1 min read
BioMidwest

New Data for Incyte Corporation’s Jakafi® (ruxolitinib) Presented at 2012 American Society of Clinical Oncology Annual Meeting

June 5, 2012
·
1 min read
Pharm Country

Alexion Pharmaceuticals Inc. to Present at William Blair & Company 32nd Annual Growth Stock Conference

June 5, 2012
·
1 min read
BioMidwest

Incyte Corporation Presents Results from a Phase I Trial of INCB024360, a Novel Oral Inhibitor of Indoleamine Dioxygenase-1 (IDO1), at American Society of Clinical Oncology

June 5, 2012
·
1 min read
Business

Düzen Selects Bruker Corporation´s MALDI Biotyper for Mass Spectrometry-based Molecular Microbial Identification

June 5, 2012
·
1 min read
Business

BioStorage Technologies, Inc. Announces Kristina Robson as Senior Director of Comprehensive Solutions

June 5, 2012
·
2 min read
Pharm Country

PhaseBio Pharmaceuticals, Inc. Received an Additional $23 Million With Completion of the Third Tranche of a Series B Financing for Advancement of Metabolic and Cardiovascular Product Portfolio

June 5, 2012
·
2 min read
Drug Development

BioSpecifics Technologies Corporation Reports Positive Phase III Data From XIAFLEX Clinical Trials

June 5, 2012
·
7 min read